iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.60−0.05 (-8.17%)
Close on Nov 16, 2026Market cap $1.52MP/E –Yield –
iSpecimen r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2024 it was $1.49M, down 7.8% from the year before. The highest annual figure on record is $1.62M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.49M | -7.8% |
| FY2023 | Dec 31, 2023 | $1.62M | +9.9% |
| FY2022 | Dec 31, 2022 | $1.47M | +67.6% |
| FY2021 | Dec 31, 2021 | $879.24K | +175.4% |
| FY2020 | Dec 31, 2020 | $319.24K | – |
See a number that looks wrong?